Anti-obesity agents
Semaglutide Jabs Show Promise in Treating Deadly Heart Failure
A trial involving over 1,145 patients has found that semaglutide, a type of weight-loss jab, can help ease symptoms of heart failure, offering new hope to the hundreds of thousands of Britons affected by the condition. The analysis, presented in the Journal of the American College of Cardiology, discovered